Neurostimulation device

Information

  • Patent Grant
  • 11266830
  • Patent Number
    11,266,830
  • Date Filed
    Monday, June 15, 2020
    4 years ago
  • Date Issued
    Tuesday, March 8, 2022
    2 years ago
Abstract
The present disclosure describes an implantable lead device that includes an internal support comb. The support comb can include one or more faces that enable the alignment, routing, and holding of the lead device's internal wires. The support comb can enable the interconnection of the wires with to the microelectrode film that includes the lead device's electrodes.
Description
BACKGROUND OF THE DISCLOSURE

Deep brain stimulation (DBS) can include neurostimulation therapy that involves electrical stimulation systems that stimulate the human brain and body. DBS can be used to treat a number of neurological disorders. DBS can involve electrically stimulating a target area of the brain.


SUMMARY OF THE DISCLOSURE

The present disclosure describes a stimulation device that can be formed into a cylindrical shape. Internally, the stimulation device can include a silicon etched support comb with faces to align, route, and hold wires. The support comb can enable the interconnection of the wires with the microelectrode film that includes the stimulation device's electrodes. The stimulation device can also include an internal support tube that can reduce mechanical detachment of the microelectrode film from its epoxy mold by providing a long edge anchoring system. The microelectrode film can be rolled into a three-dimensional configuration to increase the degrees of freedom during the assembly process.


According to at least one aspect of the disclosure an implantable lead device can include a support comb. The support comb can include an attachment face and a routing face. The routing face can include a plurality of slots. The lead device can include a microelectrode film. The microelectrode film can include a body. The body can include a plurality of electrodes. The microelectrode film can include an extension extending from the body. The extension can include a first face. The first face of the extension can include a plurality of electrical contacts coupled with the plurality of electrodes. The extension can include a second face. The second face of the extension can be coupled with the attachment face of the support comb. The lead device can include a plurality of wires. Each of the plurality of wires can pass through a respective one of the plurality of slots and couple with a respective one of the plurality of electrical contacts.


The attachment face can include a channel to route an adhesive under at least a portion of the second face of the microelectrode film. A first face of the body of the microelectrode film can be coupled with the support tube. The support tube can include a plurality of radio opaque markers that can be aligned with the plurality of electrodes. The support tube can include a plurality of merlons on a first end. The first end can be configured to mate with or receive the support comb.


The lead device can include a support tube that can include a plurality of radio opaque markers. Each of the plurality of wires can be coupled with a respective one of the plurality of electrical contacts via wire bonding.


The extension of the microelectrode film can include a first leg and a second leg. The first leg can include the first face of the extension and the second face of the extension. The second leg can include a plurality of traces coupling a subset of the plurality of electrodes to the plurality of electrical contacts.


The first leg and the second leg of the extension can be rolled around the support comb. The lead device can include an epoxy backfill of the microelectrode film to form a probe shaft.


According to at least one aspect of the disclosure, a method to manufacture an implantable lead device can include providing a support comb. The support comb can include an attachment face and a routing face. The routing face can include a plurality of slots. The method can include coupling a first portion of a microelectrode film with the attachment face of the support comb. The first portion of the microelectrode film can include a plurality of electrical contacts. The method can include positioning each of a plurality of wires through a respective one of the plurality of slots of the routing face. The method can include coupling each of the plurality of wires with a respective one of the plurality of electrical contacts. The method can include rolling a second portion of the microelectrode film about the support comb.


The method can include forming a second portion of the microelectrode film. The second portion can include a plurality of electrodes in electrical communication with the plurality of electrical contacts. The method can include forming a third portion of the microelectrode film. The third portion can include a plurality of electrical traces coupling a portion of the plurality of electrodes to a portion of the plurality of electrical contacts.


The method can include coupling a second portion of the microelectrode film to an outer face of a support tube. The second portion of the microelectrode film can include a plurality of electrodes. The method can include over molding the support comb with an epoxy.


The method can include forming a plurality of radio opaque markers in a support tube. The method can include aligning the plurality of radio opaque markers with a plurality of electrodes formed in the microelectrode film. The plurality of radio opaque markers can be offset from the plurality of electrodes.


The method can include wire bonding each of the plurality of wires with the respective one of the plurality of electrical contacts. The method can include rolling a second portion of the microelectrode film to form a cylinder. The method can include filling the cylinder with an epoxy.


The method can include under filling a channel formed in the attachment face with an epoxy to couple the first portion of the microelectrode film with the attachment face. The method can include etching the support comb in silicon.


The method can include coupling a first edge of the microelectrode film with a second edge of the microelectrode film to form a cylinder. The method can include inserting the first and second edges of the microelectrode film into a slit of a support tube.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings are not intended to be drawn to scale. Like reference numbers and designations in the various drawings indicate like elements. For purposes of clarity, not every component may be labeled in every drawing. In the drawings:



FIG. 1 illustrates an example system to perform neurostimulation.



FIG. 2 illustrates the stimulation lead for use in the system illustrated in FIG. 1.



FIG. 3 illustrates a perspective view of the distal end of the stimulation lead illustrated in FIG. 2.



FIG. 4 illustrates a top view of the microelectrode film for use in the stimulation lead illustrated in FIG. 2.



FIG. 5 illustrates the microelectrode film in a rolled configuration.



FIG. 6 illustrates an example support tube for use in the stimulation lead illustrated in FIG. 2.



FIG. 7 illustrates the microelectrode film coupled with the support tube, as viewed from the distal end of the support tube.



FIGS. 8-10 illustrate an example support comb for use in the stimulation lead illustrated in FIG. 2.



FIGS. 11-14 illustrate views of the distal end of the stimulation lead illustrated in FIG. 2.



FIG. 15 illustrates a partial view of the interface between the support comb and the microelectrode film in the stimulation lead illustrated in FIG. 2.



FIG. 16 illustrates a partial view of an example support comb that can be used in the stimulation lead illustrated in FIG. 2.



FIG. 17 illustrates a partial view of the coupling of the support comb with the support tube.



FIGS. 18 and 19 illustrate example configurations of the microelectrode film with tabs.



FIG. 20 illustrates an example support tube and markers for use in the system illustrated in FIG. 1.



FIG. 21 illustrates an example support comb with a circular configuration for use in the system illustrated in FIG. 1.



FIG. 22 illustrates an example method to manufacture the lead device for use in the system illustrated in FIG. 1.





DETAILED DESCRIPTION

The various concepts introduced above and discussed in greater detail below may be implemented in any of numerous ways, as the described concepts are not limited to any particular manner of implementation. Examples of specific implementations and applications are provided primarily for illustrative purposes.



FIG. 1 illustrates an example system 50 for performing neurostimulation. The system 50 includes a stimulation lead 100 implanted into the brain 54 of a patient 52. The stimulation lead 100 is coupled with a stimulator 58 through cables 56. The stimulator 58 generates therapeutic, electrical stimulations that can be delivered to the patient's brain 54 by the stimulation lead 100. The stimulation lead 100 can be an implantable lead device, which can be chronically or acutely implanted into the patient 52.



FIG. 2 illustrates the stimulation lead 100. The stimulation lead 100 includes a distal end 110 and a proximal end 112. The distal end 110 includes a plurality of electrodes 108. The proximal end 112 includes a plurality of terminal contacts 116. Each of the terminal contacts 116 are electrically coupled with at least one of the electrodes 108. For example, a wire (or other electrical trace) can run through the interior of the body 114 from one of the terminal contacts 116 to a contact disposed toward the distal end 110 that is in electrical communication with the electrode 108.



FIG. 3 illustrates a perspective view of the distal end 110 of the stimulation lead 100. As an overview, the distal end 110 includes a microelectrode film 104 with a plurality of electrodes 108. The microelectrode film 104 is coupled with a support tube 132. The distal end 110 also includes the support comb 102. The support comb 102 can enable the attachment of the wires 106 to the microelectrode film 104. The distal end 110 also includes a probe shaft 140. Components of the distal end 110 are described below in connection to FIGS. 4-9, among others, and the assembled distal end 110 is further described in connection to FIGS. 10-17, among others.


The distal end 110 includes a microelectrode film 104. FIG. 4 illustrates a top view of the microelectrode film 104. FIG. 4 illustrates the microelectrode film 104 in a planar configuration. The microelectrode film 104 includes a body 120 and an extension 122. The body 120 includes a plurality of electrodes 108. The extension 122 includes a plurality of contacts 118. The contacts 118 can be coupled with the electrodes 108 via traces 124.


The microelectrode film 104 includes the body 120. The body 120 can include a plurality of electrodes 108. The body 120 can include between about 4 and about 64, between about 8 and about 32, between about 8 and about 24, or between about 4 and about 12 electrodes 108. The electrodes 108 can be configured as directional or omnidirectional electrodes. For example, in an omnidirectional configuration, the electrode 108 can extend substantially the height 126 of the body 120, such that the electrode 108 wraps substantially around (e.g., at least 80%, or at least 90%) the circumference of the distal end 110 when the microelectrode film 104 is formed into a cylinder (as illustrated in FIG. 5). In a directional configuration, as illustrated in FIG. 4, the electrodes 108 only extend a portion of the height 126 of the microelectrode film 104. For example, in a directional configuration the electrodes 108 may each only extend between about 10% and about 80%, between about 10% and about 60%, between about 10% and about 40%, or between about 10% and about 25% of the height 126 of the body 120. The electrodes 108 can be grouped in column to span the height 126. One or more of the directionally configured electrodes 108 can be electrically coupled together to form an omnidirectional electrode 108. The coupling between at least two directionally configured electrodes 108 to form an omnidirectional electrode 108 can occur electrically by connecting two traces 124 within microelectrode film 104 or by connecting terminal contacts 116 via the wires 106.


The microelectrode film 104 can include a plurality of traces 124. The traces 124 can couple the electrodes 108 with one or more contacts 118. The microelectrode film 104 can include the same number of contacts 118 and electrodes 108 such that each electrode 108 is coupled with a single contact 118. The microelectrode film 104 can include fewer contacts 118 than electrodes 108, such that more than one electrode 108 is coupled with the same contact 118 (to form, for example, an omnidirectional electrode). Each trace 124 can make one or more connections with an electrode 108. For example, a trace 124 can branch into two or more periphery traces that couple with the electrode 108 at couple with the electrode 108 at several points around the periphery of the electrode 108. Making multiple connections with each of the electrodes 108 can increase the reliability of the microelectrode film 104.


The extension 122 can include the contacts 118. The contacts 118 can provide an interface where the wires 106 are coupled with the microelectrode film 104. For example, each of the wire 106 can be wire bonded or laser bonded with a respective one of the contacts 118.


The extension 122 can include a first leg 128 and a second leg 130. The contacts 118 can be disposed on a first face of the first leg 128. The first leg 128 can also include an opening 158 disposed toward each end of the first leg 128. The openings 158 can be holes through the first leg 128. The openings 158 can align with inlets that are formed in the attachment face of the support comb 102 (and described further below in relation to FIG. 8, among others). The second leg 130 can include a subset of the traces 124 that run from the contacts 118 to the electrodes 108. Running the subset of the traces 124 along the second leg 130 can enable a greater number of traces 124 (and therefore electrodes 108) to be incorporated into the microelectrode film 104 when compared to a system that routes the traces 124 along a single leg.



FIG. 5 illustrates the microelectrode film 104 in the rolled configuration. As illustrated, opposite edges of the body 120 are rolled toward one another to form a cylinder. The second leg 130 is rolled about the first leg 128 to form a second portion of the cylinder. As described in relation to FIGS. 5 and 6, among others, the body 120 can be rolled about a support tube.



FIG. 6 illustrates an example support tube 132. The support tube 132 can include a plurality of markers 134. The support tube 132 can include a slot 136. The proximal end of the support tube 132 can include a plurality of merlons 138.


The support tube 132 can include a radio opaque metal, such as a medical grade stainless steel, non-metal materials, such as plastic, or a combination thereof. The support tube 132 can include a plurality of markers 134. The markers 134 can be radio opaque. For example, the markers 134 can be visible when the stimulation lead 100 is imaged with a CT scanner or x-ray. When the support tube 132 is manufactured from a radio opaque metal, the markers 134 can be holes or voids in the body of the support tube 132. The markers 134 can pass through the wall of the support tube 132. When the markers 134 are holes through the wall of the support tube 132, the regions without the markers 134 can be relatively more radio opaque when compared to the portions of the support tube 132 with the markers 134. The electrodes 108 can be aligned with the markers 134. The electrodes 108 can be aligned with the regions between the markers 134. The support tube 132 can be manufactured in a plastic material and the markers 134 can be made radio opaque by either, a localized doping of the polymer such as Boron bombardment or by backfilling with a doped polymer for example Boron doped plastic.


The support tube 132 can include a plurality of merlons 138. The merlons 138 can be a plurality of extensions that extend from one end of the support tube 132. Each merlon 138 can be separated from a neighboring merlon 138 by a gap or crenel. Each of the merlons 138 can be about between about 0.2 mm and about 2 mm, between about 0.4 mm and about 1.5 mm, between about 0.2 mm and about 1 mm, or between about 0.4 mm and about 0.6 mm long. The merlons 138 can have a circumferential pitch of about 0.1 mm to about 2 mm, between about 0.1 mm and about 1.5 mm, between about 0.1 mm and about 1 mm, between about 0.1 mm and about 0.5 mm, or between about 0.2 mm and about 4 mm.


The merlons 138 are configured to mate with the support comb 102. The merlons 138 are configured to mate with the probe shaft of the stimulation lead 100. The probe shaft can be formed by an epoxy over-molding process. The merlons 138 can provide groves and ridged to into which the epoxy can flow and bond to form the probe shaft.


The support tube 132 can include a slot 136. The slot 136 can run the length of the support tube 132. The slot 136 can pass through the wall of the support tube 132 or can form a channel in the outer face of the support tube 132.



FIG. 7 illustrates the microelectrode film 104 coupled with the support tube 132, as viewed from the distal end of the support tube 132. A first face of the body 120, which includes the electrodes 108 can faces outward and away from the support tube 132. A second face of the microelectrode film's body 120 is coupled with the external face of the support tube 132 to form a cylinder. The opposing edges of the body 120 are inserted through the slot 136.



FIG. 8 illustrates an attachment face of the support comb 102 and a first routing face 144 of the support comb 102. The attachment face 142 includes a channel 148. The attachment face 142 of the support comb 102 is configured to couple with a face of the microelectrode film 104. The channel 148 is configured to route an adhesive under a portion of face of the microelectrode film 104 that is coupled with the attachment face 142. The channel 148 can be between about 5 μm and about 40 μm, between about 10 μm and about 30 μm, or between about 10 μm and about 20 μm. During the manufacturing of the stimulation lead 100, a face of the microelectrode film 104 can be coupled with the attachment face 142 of the support comb 102 through a mechanical means, such as a clamp. The inlets 150 can extend past the portion of the microelectrode film 104 that is coupled with the attachment face 142. An adhesive can be added to the inlets 150. Capillary action can transport the adhesive along the length of the channel 148 and under the face of the microelectrode film 104 that is coupled with the attachment face 142. Once the adhesive sets, the mechanical means for holding the microelectrode film 104 against the attachment face 142 can be released.


The support comb 102 can include a first routing face 144. The first routing face 144 can include plurality of slots 152 (which can also be referred to as channels 152). The first routing face 144 can include a slot 152 for each of the wires 106. During the manufacturing process, each of the contacts 118 can be substantially aligned with one of the slots 152 to facilitate coupling the wires 106 with contacts 118. For example, each of the wires 106 can pass through a respective slot 152 to align with a different contact 118. The pitch of the slots 152 can match the pitch of the contacts 118.



FIG. 9 illustrates a second routing face 154 of the support comb 102. The second routing face 154 is opposite the attachment face 142. The second routing face 154 can include a plurality of fingers 156. The fingers 156 are raised protrusions that can form channels 157 in the second routing face 154. Each of the channels 157 can terminate in a hole 159 that passed to the slots 152 on the first routing face 144.



FIG. 10 illustrates the second routing face 154 with wires 106 passing along the second routing face 154. The wires 106 can pass into the channels 157 defined by the fingers 156. From the channels 157, the wires 106 can pass through the hole 159 at the end of the channel 157 and into one of the respective slots 152 on the first routing face 144. The color coding of the wires 106 can enable the appropriate routing of wires 106 from each one of the terminal contacts 116 to the corresponding electrodes 108 of the distal end 110.



FIGS. 11-14 illustrate different face views of the distal end 110. Each of the views illustrated in FIGS. 11-14 illustrate a view of the distal end 110 of the stimulation lead 100 rotated 90 degrees with respect to the previous FIG. For example, FIG. 11 can be said to illustrate a top view of the distal end 110, FIG. 12 can be said to illustrate a first side view of the distal end 110, FIG. 13 can be said to illustrate a bottom view of the distal end 110, and FIG. 14 can be said to illustrate a second side view of the distal end 110. The preceding “top”, “first side,” “second side,” and “bottom” are provided for reference only as any face of the distal end 110 can serve as the “top,” “bottom,” etc. For example, the placement of the electrodes 108 around the circumference of the distal end 110 enable any face (or angle) of the distal end 110 to serve as the top, bottom, or side of the distal end 110.


Referring to FIGS. 11-14 together, among others, the distal end 110 includes the microelectrode film 104. The microelectrode film 104 includes a plurality of electrodes 108. The electrodes 108 are coupled with the terminal contacts 116 via the wires 106. The distal end 110 also includes the support comb 102. The support comb 102 can facilitate the management of the wires 106 within the shaft of the distal end 110. The support comb 102 can also secure or hold the terminating ends of the wires 106 near the contacts of the microelectrode film 104. Positing the terminating ends of the wires 106 near the contacts of the microelectrode film 104 can enable for improved efficiencies in manufacturing as the support comb 102 can provide alignment between the wires 106 and the contacts 118 of the microelectrode film 104.



FIG. 15 illustrates an enlarged view of the interface between the support comb 102 and the microelectrode film 104. FIG. 15 illustrates the microelectrode film 104 in the rolled or cylindrical configuration. The extension 122 of the microelectrode film 104 is rolled around the support comb 102 such that support comb 102 is positioned within a lumen defined by the rolled (or cylindrical) microelectrode film 104. The second leg 130 is wrapped around the support comb 102 and positioned toward the support comb's second routing face 154 (illustrated in FIG. 15 as the backside of the support comb 102). The first leg 128 can be coupled with the attachment face 142.


The first leg 128 of the microelectrode film 104 can be coupled with the attachment face 142. The first leg 128 can include a first face that includes the contacts 118 and a second face, opposite the first face, that can couple with the support comb 102. The second face can be coupled with the attachment face 142. The first leg 128 can be positioned on the attachment face 142 such that the opening 158 substantially aligns with the inlet 150. For example, before rolling the extension 122 around the support comb 102, an adhesive can be delivered to the inlet 150 through the opening 158 in the first leg 128. Through capillary action, the adhesive can flow through the channel 148 and under the first leg 128 to couples the first leg 128 (e.g., the second face of the first leg 128) with the attachment face 142.


Coupling the first leg 128 with the attachment face 142, the contacts 118 can be substantially aligned with the slots 152. The contacts 118 can be offset from the slots 152. For example, each of the contacts 118 can be positioned between neighboring slots 152. The slots 152 can enable wire management and position the wires 106 in a correct position for bonding with the contacts 118. For example, the wires 106 can pass through each of the slots 152 to align with one of the contacts 118. The wires 106 can be coupled with the contacts 118. The wires 106 can be wire bonded or welded with the contacts 118.



FIG. 16 illustrates an enlarged view of the support comb 102. FIG. 16 substantially illustrates the back side of the support comb 102 (and distal end 110) with respect to FIG. 15.


As illustrated, the second leg 130 of the microelectrode film 104 is rolled around the support comb 102. The wires 106 pass along the second routing face 154 of the support comb 102. Each of the wires 106 pass through a channel formed by the fingers 156. The wires 106 can pass through a hole 159 formed at the end of the channel 157 and into the slots 152. The fingers 156 (and the channels formed thereby) can enable routing of the wires 106 along the support comb 102 and to the slots 152 where the wires 106 can be coupled with the contacts 118.



FIG. 17 illustrates an enlarged view of the coupling of the support comb 102 with the support tube 132. A first end of the support comb 102 can include a knob or other structure that is configured to fit within a portion of the support tube 132. The merlons 138 can surround the knob at the first end of the support comb 102. The probe shaft 140 can be formed through an epoxy over molding process. The epoxy can flow into the areas between the merlons 138 to form a probe shaft 140 that is coupled with the support tube 132. The epoxy of the probe shaft 140 can encase the support comb 102 and the second leg 130 within the body of stimulation lead's distal end 110. The probe shaft 140 can be formed from an injection molding or micromachining process.



FIGS. 18 and 19 illustrate an example configuration of the microelectrode film 104 and method for forming the microelectrode film 104 into a cylinder. FIG. 19 illustrates the body 120 portion of the microelectrode film 104 in a partially rolled state. A first edge of the body 120 can include a plurality of tabs 160. The opposite edge (or towards the opposite edge) can include a plurality of slots 162. The body 120 can include a slot 162 for each of the tab 160. The tabs 160 can be tapered—narrowing as the tab 160 extends from the body 120. For example, the tabs 160 can be shaped like the head of an arrow. Each of the tabs 160 can slide into a respective one of the slots 162. The tabs 160 can include a barb that locks the tab 160 into the slot 162 once the tab 160 is inserted into the slot 162 past the barb. FIG. 19 illustrates the body 120 with the tabs 160 fully inserted into the slots 162 to form a cylinder.



FIG. 20 illustrates an example support tube 132 and markers 134. The example support tube 132 illustrated in FIG. 20 can be manufactured from a non-magnetic or non-radio opaque material. The markers 134 can be manufactured from a radio opaque material. The support tube 132 can include a plurality of grooves 164. The grooves 164 can be shaped to receive the markers 134. The markers 134 can be secured into the grooves 164 with an adhesive, clip, or pressure fitting. When the microelectrode film 104 is coupled with the support tube 132, the electrodes 108 can be aligned with the markers 134.



FIG. 21 illustrates an example support comb 102 in a circular configuration. The support comb 102 can include a plurality of slots 152 around the circumference of the support comb 102. The extension of the microelectrode film 104 can be disk shaped and can include a plurality of contacts 118 distributed toward the circumference of the extension. The wires 106 can pass through each of the slots 152 toward the contacts 118. The slots 152 can align the wires 106 with the contacts 118. The wires 106 can be wire bonded or welded to the contacts 118.



FIG. 22 illustrates an example method 200 to manufacture a lead device. The method 200 can include providing a support comb (BLOCK 202). The method 200 can include positioning a plurality of wires (BLOCK 204). The method 200 can include coupling the support comb with a microelectrode film (BLOCK 206). The method 200 can include coupling the wires with the microelectrode film (BLOCK 208). The method 200 can include rolling the microelectrode film (BLOCK 210).


As set forth above, the method 200 can include providing a support comb (BLOCK 202). Referring also to FIGS. 1-21, the support comb 102 can include an attachment face 142 and first routing face 144. The first routing face 144 can include a plurality of slots 152. The microelectrode film 104 can include a second routing face 154. The second routing face 154 can include a plurality of fingers 156 that form channels on the second routing face 154. The channels 157 can terminate in a hole 159 that connects the channels 157 of the second routing face 154 with the slots 152 of the first routing face 144. The attachment face 142 can include a channel 148.


The support comb 102 can be manufactured by an injection molding process, a micromachining process, a photolithography process, or 3D-printing process. The support comb 102 can be manufactured from silicon, plastic, metal, liquid crystal polymers (LCP), or other material. Radio opaque materials can include included into the support comb 102 to enable the distal end 110 to be visualized during an X-ray. For example, the polymers used in an injection molding process can be doped with a radio opaque material such as Barium Sulfate (BaSO4), Boron, or metal rings, bands, or components can be incorporated into the support comb 102.


The method 200 can include positioning the wires (BLOCK 204). Referring to FIG. 10, among others, the wires 106 can uncoil and run along the second routing face 154. The second routing face 154 can arrange the wires 106. The second routing face 154 can include a plurality of fingers 156 that can define channels 157. A wire 106 can pass through a respective channel 157 and through a hole 159 at the end of the channel 157 that couples the channel 157 with a slot 152. Each of the wires 106 can pass through a respective one of the slots 152. The slots 152 can hold and position the wires 106. For example, the slots 152 can hold each of the wires 106 in a fixed proximity to a respective contact 118.


The method 200 can include coupling the support comb 102 with a microelectrode film 104 (BLOCK 206). The microelectrode film 104 can include different portions. For example, the microelectrode film 104 can include a body 120 and an extension 122. The body 120 can include a plurality of electrodes 108. The extension 122 can include a plurality of legs. One of the legs can include a plurality of contacts 118. Both the extension 122 and the body 120 can include a plurality of traces 124.


The microelectrode film 104 can include a stack of insulating and conducting layers. The microelectrode film can be a thin-film, microelectromechanical systems (MEMS) electrode film. The conducting layers can include the traces 124, the contacts 118, and the electrodes 108. The different conducting layers can be isolated from one another by the insulating layers. The insulating layers can also isolate the conducting layers (or portions thereof) from the external environment. The microelectrode film 104 can be manufactured as a planar film using additive manufacturing processes.


The microelectrode film 104 can be coupled with the support comb 102 by coupling a first portion of the microelectrode film 104 with the attachment face 142. For example, a portion of the extension 122 can be coupled with the attachment face 142. The first leg 128 of the extension 122, which can include a plurality of contacts 118 can be coupled with the attachment face 142. The face opposite the face with the contacts 118 can be coupled with the attachment face 142 such that the contacts 118 faces away from the support comb 102.


When coupling the microelectrode film 104 with the support comb 102, the openings 158 of the extension 122 can be aligned with the inlets 150 of the support comb 102. The microelectrode film 104 can be coupled with the support comb 102 by applying an adhesive to the inlets 150. Capillary force can drive the adhesive from the inlets 150 and through the channel 148 to underfill the space between the microelectrode film 104 and the support comb 102 formed by the channel 148. Once cured, the adhesive can couple the microelectrode film 104 with the support comb 102.


The method 200 can include coupling the wires with the microelectrode film (BLOCK 208). Also, Referring to FIG. 15, among others, the wires 106 can pass through a respective channel on the second routing face 154 and into a respective slot 152. The slot 152 can position each of the wires 106 near one of the contacts 118. The wires 106 can be coupled with the contacts 118 with wire bonding, welding, or laser bonding.


The method 200 can include rolling the microelectrode film (BLOCK 210). The extension 122 of the microelectrode film 104 can be rolled about the support comb 102. The body 120 of the microelectrode film 104 can be rolled about the support comb 102. Rolling the extension 122 about the support comb 102 can place the second leg 130 of the extension 122 near the second routing face 154 of the support comb 102.


The body 120 of the microelectrode film 104 can be rolled about the support tube 132. The microelectrode film 104 can be coupled with the outer face of the support tube 132. The support tube 132 can include a slot 136. Opposite edges of the body 120 can be inserted into the slot 136.


Once the microelectrode film 104 is rolled, the microelectrode film 104 and support comb 102 can be placed in a mold. The mold can be filled with an epoxy. The epoxy over molding can form a probe shaft 140. The probe shaft 140 can encase the extension 122, the support comb 102, and at least a portion of the wires 106. The probe shaft 140 can flow into the merlons 138 and couples with the support tube 132.


While operations are depicted in the drawings in a particular order, such operations are not required to be performed in the particular order shown or in sequential order, and all illustrated operations are not required to be performed. Actions described herein can be performed in a different order.


The separation of various system components does not require separation in all implementations, and the described program components can be included in a single hardware or software product.


Having now described some illustrative implementations, it is apparent that the foregoing is illustrative and not limiting, having been presented by way of example. In particular, although many of the examples presented herein involve specific combinations of method acts or system elements, those acts and those elements may be combined in other ways to accomplish the same objectives. Acts, elements and features discussed in connection with one implementation are not intended to be excluded from a similar role in other implementations or implementations.


The phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including” “comprising” “having” “containing” “involving” “characterized by” “characterized in that” and variations thereof herein, is meant to encompass the items listed thereafter, equivalents thereof, and additional items, as well as alternate implementations consisting of the items listed thereafter exclusively. In one implementation, the systems and methods described herein consist of one, each combination of more than one, or all of the described elements, acts, or components.


As used herein, the term “about” and “substantially” will be understood by persons of ordinary skill in the art and will vary to some extent depending upon the context in which it is used. If there are uses of the term which are not clear to persons of ordinary skill in the art given the context in which it is used, “about” will mean up to plus or minus 10% of the particular term.


Any references to implementations or elements or acts of the systems and methods herein referred to in the singular may also embrace implementations including a plurality of these elements, and any references in plural to any implementation or element or act herein may also embrace implementations including only a single element. References in the singular or plural form are not intended to limit the presently disclosed systems or methods, their components, acts, or elements to single or plural configurations. References to any act or element being based on any information, act or element may include implementations where the act or element is based at least in part on any information, act, or element.


Any implementation disclosed herein may be combined with any other implementation or embodiment, and references to “an implementation,” “some implementations,” “one implementation” or the like are not necessarily mutually exclusive and are intended to indicate that a particular feature, structure, or characteristic described in connection with the implementation may be included in at least one implementation or embodiment. Such terms as used herein are not necessarily all referring to the same implementation. Any implementation may be combined with any other implementation, inclusively or exclusively, in any manner consistent with the aspects and implementations disclosed herein.


The indefinite articles “a” and “an,” as used herein in the specification and in the claims, unless clearly indicated to the contrary, should be understood to mean “at least one.”


References to “or” may be construed as inclusive so that any terms described using “or” may indicate any of a single, more than one, and all of the described terms. For example, a reference to “at least one of ‘A’ and ‘B’” can include only ‘A’, only ‘B’, as well as both ‘A’ and ‘B’. Such references used in conjunction with “comprising” or other open terminology can include additional items.


Where technical features in the drawings, detailed description or any claim are followed by reference signs, the reference signs have been included to increase the intelligibility of the drawings, detailed description, and claims. Accordingly, neither the reference signs nor their absence have any limiting effect on the scope of any claim elements.


The systems and methods described herein may be embodied in other specific forms without departing from the characteristics thereof. The foregoing implementations are illustrative rather than limiting of the described systems and methods. Scope of the systems and methods described herein is thus indicated by the appended claims, rather than the foregoing description, and changes that come within the meaning and range of equivalency of the claims are embraced therein.

Claims
  • 1. An implantable lead, comprising a support structure; anda microelectrode film comprising: a body having a plurality of electrodes;a plurality of tabs along a first edge of the body;a plurality of slots along a second edge of the body opposite of the first edge, each of the plurality of slots to hold a corresponding tab of the plurality of tabs to define a volume at least partially through the body of the microelectrode film; andan extension coupled with the support structure, the extension comprising a plurality of contacts and a plurality of traces, each of the plurality of contacts coupled with one or more of the plurality of electrodes via at least one of the plurality of traces.
  • 2. The implantable lead of claim 1, wherein the extension comprises a leg, the leg having the plurality of contacts electrically coupled with one or more of the plurality of electrodes of the body.
  • 3. The implantable lead of claim 1, wherein the extension comprises a leg, the leg having a subset of the plurality of traces to couple each of the plurality of contacts with one or more of the plurality of electrodes.
  • 4. The implantable lead of claim 1, wherein the extension comprises a first leg and a second leg, the first leg coupled with the second leg along a first edge and a second edge of the extension to define a volume at least partially through the extension of the microelectrode film.
  • 5. The implantable lead of claim 1, further comprising the support structure disposed at least partially within a volume defined by the extension, the support structure at least partially coupled with a leg of the extension.
  • 6. The implantable lead of claim 1, further comprising each of the plurality of tabs of the microelectrode film having an end and a base, the end having a width less than a width of the base.
  • 7. The implantable lead of claim 1, further comprising each of the plurality of slots of the microelectrode film having a barb, the barb to secure the corresponding tab of the plurality of tabs.
  • 8. The implantable lead of claim 1, further comprising a second support structure disposed within the volume defined through the body of the microelectrode film, the second support structure at least partially coupled with a face of the body, the second support structure having a plurality of radiopaque markers.
  • 9. The implantable lead of claim 1, further comprising a second support structure having a plurality of extensions each separated by a gap, each of the plurality of extensions to couple with the support structure.
  • 10. The implantable lead of claim 1, further comprising the support structure having a face to mechanically couple with at least a portion of the extension of the microelectrode film.
  • 11. The implantable lead of claim 1, further comprising the support structure having a face, the face defining a plurality of channels, each of the plurality of channels to pass at least one of a plurality of wires electrically coupled with the microelectrode film.
  • 12. The implantable lead of claim 1, further comprising a proximal end and a distal end opposite of the proximal end, the proximal end having a plurality of terminal contacts to electrically couple with the plurality of electrodes disposed on the distal end.
  • 13. The implantable lead of claim 1, further comprising a probe shaft disposed on an end of the support structure, the probe shaft to encase at least a portion of the extension.
  • 14. A method, comprising: providing an implantable lead device, the implantable lead device having: a support structure; anda microelectrode film comprising: a body having a plurality of electrodes;a plurality of tabs along a first edge of the body;a plurality of slots along a second edge of the body opposite of the first edge, each of the plurality of slots to hold a corresponding tab of the plurality of tabs to define a volume at least partially through the body of the microelectrode film; andan extension coupled with the support structure, the extension comprising a plurality of contacts and a plurality of traces, each of the plurality of contacts coupled with one or more of the plurality of electrodes via at least one of the plurality of traces.
  • 15. The method of claim 14, wherein the implantable lead device includes each of the plurality of tabs of the microelectrode film having an end and a base, the end having a width less than a width of the base.
  • 16. The method of claim 14, wherein the implantable lead device includes each of the plurality of slots of the microelectrode film having a barb, the barb to secure the corresponding tab of the plurality of tabs.
  • 17. The method of claim 14, wherein the implantable lead device includes the support structure disposed at least partially within a volume defined by the extension, the support structure at least partially coupled with a leg of the extension.
  • 18. The method of claim 14, wherein the implantable lead device includes a second support structure disposed within the volume defined through the body of the microelectrode film, the second support structure at least partially coupled with a face of the body, the second support structure having a plurality of radiopaque markers.
  • 19. The method of claim 14, further comprising the support structure having a face, the face defining a plurality of channels, each of the plurality of channels to pass at least one of a plurality of wires electrically coupled with the microelectrode film.
  • 20. The method of claim 14, wherein the implantable lead device includes a probe shaft disposed on an end of the support structure, the probe shaft to encase at least a portion of the extension.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims priority under 35 U.S.C. § 120 as a continuation of U.S. patent application Ser. No. 16/901,583, titled “NEUROSTIMULATION DEVICE,” filed Jun. 15, 2020, which claims priority under 35 U.S.C. § 120 as a continuation of U.S. patent application Ser. No. 15/910,278, titled “NEUROSTIMULATION DEVICE,” filed Mar. 2, 2018, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (835)
Number Name Date Kind
4245645 Arseneault et al. Jan 1981 A
4550733 Liss et al. Nov 1985 A
4837049 Byers et al. Jun 1989 A
4917093 Dufresne et al. Apr 1990 A
4928297 Tsutsui et al. May 1990 A
4969468 Byers et al. Nov 1990 A
4989617 Memberg et al. Feb 1991 A
5095905 Klepinski Mar 1992 A
5215088 Normann et al. Jun 1993 A
5237996 Waldman et al. Aug 1993 A
5345936 Pomeranz et al. Sep 1994 A
5391250 Cheney et al. Feb 1995 A
5400784 Durand et al. Mar 1995 A
5419777 Hofling May 1995 A
5458629 Baudino et al. Oct 1995 A
5496369 Howard, III Mar 1996 A
5524338 Martyniuk et al. Jun 1996 A
5628317 Starkebaum et al. May 1997 A
5643330 Holsheimer et al. Jul 1997 A
5679355 Alexander et al. Oct 1997 A
5683422 Rise Nov 1997 A
5697651 Fernandes Dec 1997 A
5697975 Howard et al. Dec 1997 A
5702429 King Dec 1997 A
5713922 King Feb 1998 A
5713923 Ward et al. Feb 1998 A
5716377 Rise et al. Feb 1998 A
5727552 Ryan Mar 1998 A
5752979 Benabid May 1998 A
5755759 Cogan May 1998 A
5782798 Rise Jul 1998 A
5797970 Pouvreau Aug 1998 A
5800474 Benabid et al. Sep 1998 A
5800535 Howard, III Sep 1998 A
5814092 King Sep 1998 A
5824029 Weijand et al. Oct 1998 A
5792186 Rise Nov 1998 A
5833709 Rise et al. Nov 1998 A
5833714 Loeb Nov 1998 A
5843148 Gijsbers et al. Dec 1998 A
5893883 Torgerson et al. Apr 1999 A
5913882 King Jun 1999 A
5921924 Avitall Jul 1999 A
5927277 Baudino et al. Jul 1999 A
5941906 Barreras et al. Aug 1999 A
5957958 Schulman et al. Sep 1999 A
5975085 Rise Nov 1999 A
5978702 Ward et al. Nov 1999 A
5991668 Leinders et al. Nov 1999 A
6011996 Gielen et al. Jan 2000 A
6018682 Rise Jan 2000 A
6024095 Stanley, III Feb 2000 A
6033403 Tu et al. Mar 2000 A
6038480 Hrdlicka et al. Mar 2000 A
6050992 Nichols Apr 2000 A
6094598 Elsberry et al. Jul 2000 A
6104960 Duysens et al. Aug 2000 A
6109269 Rise et al. Aug 2000 A
6125300 Weijand et al. Sep 2000 A
6128537 Rise Oct 2000 A
6129685 Howard, III Oct 2000 A
6161047 King et al. Dec 2000 A
6205359 Boveja Mar 2001 B1
6205361 Kuzma et al. Mar 2001 B1
6216043 Swanson et al. Apr 2001 B1
6227203 Rise et al. May 2001 B1
6253109 Gielen Jun 2001 B1
6253110 Brabec et al. Jun 2001 B1
6263237 Rise Jul 2001 B1
6266564 Hill et al. Jul 2001 B1
6295476 Schaenzer Sep 2001 B1
6301492 Zonenshayn Oct 2001 B1
6319241 King et al. Nov 2001 B1
6330466 Hofmann et al. Dec 2001 B1
6337997 Rise Jan 2002 B1
6343226 Sunde et al. Jan 2002 B1
6353762 Baudino et al. Mar 2002 B1
6356784 Lozano et al. Mar 2002 B1
6356786 Rezai et al. Mar 2002 B1
6356787 Rezai et al. Mar 2002 B1
6364875 Stanley, III Apr 2002 B1
6366813 DiLorenzo Apr 2002 B1
6374140 Rise Apr 2002 B1
6375666 Mische Apr 2002 B1
6379353 Nichols Apr 2002 B1
6415187 Kuzma et al. Jul 2002 B1
6434431 Camps et al. Aug 2002 B1
6459936 Fischell et al. Oct 2002 B2
6479999 Demeester et al. Nov 2002 B1
6484059 Gielen Nov 2002 B2
6493590 Wessman et al. Dec 2002 B1
6510347 Borkan Jan 2003 B2
6529774 Greene Mar 2003 B1
6538443 Morich et al. Mar 2003 B2
6549812 Smits Apr 2003 B1
6556873 Smits Apr 2003 B1
6560472 Hill et al. May 2003 B2
6560486 Osorio et al. May 2003 B1
6581046 Ahissar Jun 2003 B1
6587733 Cross et al. Jul 2003 B1
6591128 Wu et al. Jul 2003 B1
6594524 Esteller et al. Jul 2003 B2
6597953 Boling Jul 2003 B2
6643552 Edell et al. Nov 2003 B2
6671544 Baudino Dec 2003 B2
6675046 Holsheimer Jan 2004 B2
6687538 Hrdlicka et al. Feb 2004 B1
6690973 Hill et al. Feb 2004 B2
6708064 Rezai Mar 2004 B2
6718208 Hill et al. Apr 2004 B2
6718211 Smits Apr 2004 B2
6741893 Smits May 2004 B2
6745079 King Jun 2004 B2
6757970 Kuzma et al. Jul 2004 B1
6795737 Gielen et al. Sep 2004 B2
6804552 Thompson et al. Oct 2004 B2
6818396 Bloch et al. Nov 2004 B1
6829498 Kipke et al. Dec 2004 B2
6850802 Holsheimer Feb 2005 B2
6871098 Nuttin et al. Mar 2005 B2
6882881 Lesser et al. Apr 2005 B1
6892097 Holsheimer May 2005 B2
6892438 Hill et al. May 2005 B1
6904306 Wu et al. Jun 2005 B1
6909920 Lokhoff et al. Jun 2005 B2
6920359 Meadows et al. Jul 2005 B2
6928320 King Aug 2005 B2
6950706 Rodriguez et al. Sep 2005 B2
6950709 Baudino Sep 2005 B2
6978171 Goetz et al. Dec 2005 B2
6978178 Sommer et al. Dec 2005 B2
6999819 Swoyer et al. Feb 2006 B2
7006859 Osorio et al. Feb 2006 B1
7010351 Firlik et al. Mar 2006 B2
7010356 Jog et al. Mar 2006 B2
7024246 Acosta et al. Apr 2006 B2
7035690 Goetz Apr 2006 B2
7047082 Schrom et al. May 2006 B1
7047084 Erickson et al. May 2006 B2
7050856 Stypulkowski May 2006 B2
7051419 Schrom et al. May 2006 B2
7061240 Ham et al. Jun 2006 B2
7063767 Tyson et al. Jun 2006 B1
7076292 Forsberg Jul 2006 B2
7077822 Howard, III Jul 2006 B1
7107104 Keravel et al. Sep 2006 B2
7133718 Bakken et al. Nov 2006 B2
7146222 Boling Dec 2006 B2
7151961 Whitehurst et al. Dec 2006 B1
7174219 Wahlstrand et al. Feb 2007 B2
7177701 Pianca Feb 2007 B1
7181288 Rezai et al. Feb 2007 B1
7184829 Hill et al. Feb 2007 B2
7187978 Malek et al. Mar 2007 B2
7191016 Marshall et al. Mar 2007 B2
7191018 Gielen et al. Mar 2007 B2
7198626 Lee et al. Apr 2007 B2
7200439 Zdeblick et al. Apr 2007 B2
7203548 Whitehurst et al. Apr 2007 B2
7204798 Zdeblick et al. Apr 2007 B2
7204833 Osorio et al. Apr 2007 B1
7209787 DiLorenzo Apr 2007 B2
7212851 Donoghue et al. May 2007 B2
7212867 Van Venrooij et al. May 2007 B2
7214189 Zdeblick May 2007 B2
7216000 Sieracki et al. May 2007 B2
7216001 Hacker et al. May 2007 B2
7231256 Wahlstrand et al. Jun 2007 B2
7236822 Dobak, III Jun 2007 B2
7242984 DiLorenzo Jul 2007 B2
7276061 Schaer et al. Oct 2007 B2
7280867 Frei et al. Oct 2007 B2
7282030 Frei et al. Oct 2007 B2
7282050 Starkebaum et al. Oct 2007 B2
7286878 Stypulkowski Oct 2007 B2
7286882 Cole Oct 2007 B2
7288066 Drew Oct 2007 B2
7289851 Gunderson et al. Oct 2007 B2
7289852 Helfinstine et al. Oct 2007 B2
7295880 Gielen Nov 2007 B2
7298143 Jaermann et al. Nov 2007 B2
7307223 Tyson et al. Dec 2007 B2
7313430 Urquhart et al. Dec 2007 B2
7313440 Miesel Dec 2007 B2
7315759 Markowitz et al. Jan 2008 B2
7317947 Wahlstrand et al. Jan 2008 B2
7317948 King et al. Jan 2008 B1
7319899 Keizer Jan 2008 B2
7319904 Cross et al. Jan 2008 B2
7321798 Muhlenberg et al. Jan 2008 B2
7321837 Osorio et al. Jan 2008 B2
7322832 Kronich et al. Jan 2008 B2
7328057 Freas et al. Feb 2008 B2
7328068 Spinelli et al. Feb 2008 B2
7328069 Gerber Feb 2008 B2
7330760 Heruth et al. Feb 2008 B2
7337010 Howard et al. Feb 2008 B2
7343206 Sage et al. Mar 2008 B2
7346395 Lozano et al. Mar 2008 B2
7356369 Phillips et al. Apr 2008 B2
7359837 Drew Apr 2008 B2
7366572 Heruth et al. Apr 2008 B2
7367956 King May 2008 B2
7369891 Augustijn et al. May 2008 B2
7369893 Gunderson May 2008 B2
7369894 Gerber May 2008 B2
7385443 Denison Jun 2008 B1
7388378 Gray et al. Jun 2008 B2
7389147 Wahlstrand et al. Jun 2008 B2
7390311 Hildebrand et al. Jun 2008 B2
7391257 Denison et al. Jun 2008 B1
7392089 Wahlstrand et al. Jun 2008 B2
7395113 Heruth et al. Jul 2008 B2
7400927 Litvin Jul 2008 B1
7403820 DiLorenzo Jul 2008 B2
7406351 Wesselink Jul 2008 B2
7418292 Shafer Aug 2008 B2
7421297 Giftakis et al. Sep 2008 B2
7427280 Gerber Sep 2008 B2
7429938 Corndorf Sep 2008 B1
7433734 King Oct 2008 B2
7442183 Baudino et al. Oct 2008 B2
7447545 Heruth et al. Nov 2008 B2
7450996 MacDonald et al. Nov 2008 B2
7463917 Martinez Dec 2008 B2
7463928 Lee et al. Dec 2008 B2
7474247 Heinks et al. Jan 2009 B1
7479910 Heinks et al. Jan 2009 B1
7483748 Torgerson et al. Jan 2009 B2
7489966 Leinders et al. Feb 2009 B2
7489970 Lee et al. Feb 2009 B2
7491181 Heruth et al. Feb 2009 B2
7497844 Spear et al. Mar 2009 B2
7497863 Solar et al. Mar 2009 B2
7502217 Zhao et al. Mar 2009 B2
7505815 Lee et al. Mar 2009 B2
7505869 Hartlaub Mar 2009 B2
7515961 Germanson et al. Apr 2009 B2
7519431 Goetz et al. Apr 2009 B2
7519432 Bolea et al. Apr 2009 B2
7520890 Phillips Apr 2009 B2
7526339 Lahti et al. Apr 2009 B2
7526340 Drew Apr 2009 B2
7526341 Goetz et al. Apr 2009 B2
7529582 DiLorenzo May 2009 B1
7529586 Wahlstrand et al. May 2009 B2
7542803 Heruth et al. Jun 2009 B2
7546164 King Jun 2009 B2
7546166 Michels et al. Jun 2009 B2
7548775 Kipke et al. Jun 2009 B2
7548786 Lee et al. Jun 2009 B2
7551951 Osorio et al. Jun 2009 B1
7551960 Forsberg et al. Jun 2009 B2
7555345 Wahlstrand et al. Jun 2009 B2
7561921 Phillips et al. Jul 2009 B2
7563141 Alexander et al. Jul 2009 B2
7563541 Howard et al. Jul 2009 B2
7578819 Bleich et al. Aug 2009 B2
7580756 Schulte et al. Aug 2009 B2
7582387 Howard et al. Sep 2009 B2
7590451 Tronnes et al. Sep 2009 B2
7590453 Heruth et al. Sep 2009 B2
7590455 Heruth et al. Sep 2009 B2
7591970 Olson Sep 2009 B2
7594828 Alexander et al. Sep 2009 B2
7594889 St. Ores et al. Sep 2009 B2
7596399 Singhal et al. Sep 2009 B2
7596408 Singhal et al. Sep 2009 B2
7596415 Brabec et al. Sep 2009 B2
7599730 Hunter et al. Oct 2009 B2
7603161 Wurmfeld et al. Oct 2009 B2
7603177 Sieracki et al. Oct 2009 B2
7604629 Gerber et al. Oct 2009 B2
7604644 Schulte et al. Oct 2009 B2
7608458 Soykan et al. Oct 2009 B2
7610083 Drew et al. Oct 2009 B2
7611483 Gerber et al. Nov 2009 B2
7614743 Geiger Nov 2009 B2
7615015 Coleman Nov 2009 B2
7616998 Nuttin et al. Nov 2009 B2
7617002 Goetz Nov 2009 B2
7620454 Dinsmoor et al. Nov 2009 B2
7622303 Soykan et al. Nov 2009 B2
7622988 Denison et al. Nov 2009 B2
7623053 Terry et al. Nov 2009 B2
7623918 Goetz Nov 2009 B2
7623919 Goetz et al. Nov 2009 B2
7623923 Gerber et al. Nov 2009 B2
7623930 Zeijlemaker et al. Nov 2009 B2
7624293 Osorio et al. Nov 2009 B2
7628780 Bonner et al. Dec 2009 B2
7631415 Phillips et al. Dec 2009 B2
7632225 Stypulkowski Dec 2009 B2
7635541 Scott et al. Dec 2009 B2
7637867 Zdeblick Dec 2009 B2
7640059 Forsberg et al. Dec 2009 B2
7640060 Zdeblick Dec 2009 B2
7641992 Howard et al. Jan 2010 B2
7642013 Howard et al. Jan 2010 B2
7647111 Ries et al. Jan 2010 B2
7647116 Bauhahn Jan 2010 B2
7647117 Bauhahn Jan 2010 B2
7647121 Wahlstrand et al. Jan 2010 B2
7650291 Rosenfeld et al. Jan 2010 B2
7653433 Lozano et al. Jan 2010 B2
7657318 King et al. Feb 2010 B2
7657319 Goetz et al. Feb 2010 B2
7660620 Zeijlemaker et al. Feb 2010 B2
7660630 Dudding et al. Feb 2010 B2
7662140 Heruth et al. Feb 2010 B2
7662509 Howard et al. Feb 2010 B2
7663066 Tyson et al. Feb 2010 B2
7664551 Cigaina Feb 2010 B2
7664552 Wahlstrand et al. Feb 2010 B2
7668601 Hegland et al. Feb 2010 B2
7671594 Gray Mar 2010 B2
7676271 Wahlstrand et al. Mar 2010 B2
7676273 Goetz et al. Mar 2010 B2
7676274 Hung et al. Mar 2010 B2
7680540 Jensen et al. Mar 2010 B2
7682355 Gerber et al. Mar 2010 B2
7682745 Howard et al. Mar 2010 B2
7684860 Wahlstrand et al. Mar 2010 B2
7684866 Fowler et al. Mar 2010 B2
7684873 Gerber Mar 2010 B2
7689289 King Mar 2010 B2
7697972 Verard et al. Apr 2010 B2
7697995 Cross et al. Apr 2010 B2
7706124 Zhao et al. Apr 2010 B2
7706889 Gerber et al. Apr 2010 B2
7711421 Shafer et al. May 2010 B2
7711428 Janzig et al. May 2010 B2
7711436 Stone May 2010 B2
7713194 Zdeblick May 2010 B2
7713195 Zdeblick May 2010 B2
7720548 King May 2010 B2
7729768 White et al. Jun 2010 B2
7729780 Vardiman Jun 2010 B2
7738958 Zdeblick et al. Jun 2010 B2
7742823 King et al. Jun 2010 B2
7756588 Jog et al. Jul 2010 B2
7765012 Gerber Jul 2010 B2
7769472 Gerber Aug 2010 B2
7797029 Gibson et al. Sep 2010 B2
7822482 Gerber Oct 2010 B2
7822483 Stone et al. Oct 2010 B2
7853303 Nikumb et al. Dec 2010 B2
7877149 Zdeblick Jan 2011 B2
7899539 Whitehurst et al. Mar 2011 B2
7925329 Zdeblick et al. Apr 2011 B2
7930035 DiLorenzo Apr 2011 B2
7935056 Zdeblick May 2011 B2
7941202 Hetke et al. May 2011 B2
7945329 Bedenbaugh May 2011 B2
7945336 Sauter-Starace et al. May 2011 B2
7969161 Behzadi et al. Jun 2011 B2
7974705 Zdeblick et al. Jul 2011 B2
7978064 Zdeblick et al. Jul 2011 B2
7979105 Kipke et al. Jul 2011 B2
7983751 Zdeblick et al. Jul 2011 B2
7991481 Benabid et al. Aug 2011 B2
8000794 Lozano Aug 2011 B2
8000808 Hegland et al. Aug 2011 B2
8010202 Shah et al. Aug 2011 B2
8024022 Schulman et al. Sep 2011 B2
8032224 Miesel et al. Oct 2011 B2
8036737 Goetz et al. Oct 2011 B2
8036743 Savage et al. Oct 2011 B2
8036748 Zdeblick et al. Oct 2011 B2
8055334 Savage et al. Nov 2011 B2
8055353 Kreidler et al. Nov 2011 B2
8090450 Swoyer et al. Jan 2012 B2
8099170 Jensen et al. Jan 2012 B2
8108049 King Jan 2012 B2
8114021 Robertson et al. Feb 2012 B2
8115618 Robertson et al. Feb 2012 B2
8121687 Jensen et al. Feb 2012 B2
8121702 King Feb 2012 B2
8123684 Zdeblick Feb 2012 B2
8170676 Greenberg et al. May 2012 B2
8171621 Swanson et al. May 2012 B2
8172762 Robertson May 2012 B2
8187161 Li et al. May 2012 B2
8195308 Frank et al. Jun 2012 B2
8204586 Zdeblick Jun 2012 B2
8224417 Vetter Jul 2012 B2
8224462 Westlund et al. Jul 2012 B2
8244377 Pianca et al. Aug 2012 B1
8258962 Robertson et al. Sep 2012 B2
8261428 Fang et al. Sep 2012 B2
8271094 Moffitt et al. Sep 2012 B1
8280514 Lozano et al. Oct 2012 B2
8295943 Eggen et al. Oct 2012 B2
8315686 Llinas et al. Nov 2012 B2
8321025 Bedenbaugh Nov 2012 B2
8332020 Zdeblick Dec 2012 B2
8332046 Anderson et al. Dec 2012 B2
8355768 Masmanidis et al. Jan 2013 B2
8374703 Imran Feb 2013 B2
8412347 Zdeblick Apr 2013 B2
8463353 Seymour Jun 2013 B2
8463398 Jackson et al. Jun 2013 B2
8467877 Imran Jun 2013 B2
8473061 Moffitt et al. Jun 2013 B2
8473069 Bi et al. Jun 2013 B2
8489203 Ortmann Jul 2013 B2
8509872 Lee et al. Aug 2013 B2
8509876 Karmarkar Aug 2013 B2
8509920 Wahlstrand et al. Aug 2013 B2
8560085 Moffitt et al. Oct 2013 B2
8565894 Vetter et al. Oct 2013 B2
8571665 Moffitt et al. Oct 2013 B2
8583253 Shi et al. Nov 2013 B1
8620452 King et al. Dec 2013 B2
8626312 King et al. Jan 2014 B2
8634934 Kokones et al. Jan 2014 B2
8644903 Osa et al. Feb 2014 B1
8649879 Digiore et al. Feb 2014 B2
8666509 Howard et al. Mar 2014 B2
8694105 Martens et al. Apr 2014 B2
8694123 Wahlstrand et al. Apr 2014 B2
8694127 Pianca et al. Apr 2014 B2
8731673 Vetter et al. May 2014 B2
8738154 Zdeblick et al. May 2014 B2
8744596 Howard Jun 2014 B2
8755906 Moffitt et al. Jun 2014 B2
8762065 DiLorenzo Jun 2014 B2
8774891 Osa et al. Jul 2014 B1
8788056 King et al. Jul 2014 B2
8788063 Chen Jul 2014 B2
8788064 Mercanzini et al. Jul 2014 B2
8792993 Pianca et al. Jul 2014 B2
8800140 Hetke et al. Aug 2014 B2
8825175 King Sep 2014 B2
8831739 McCreery et al. Sep 2014 B2
8831742 Pianca et al. Sep 2014 B2
8849369 Cogan et al. Sep 2014 B2
8849415 Bedenbaugh Sep 2014 B2
8862242 Pianca Oct 2014 B2
8874232 Chen Oct 2014 B2
8875391 Pianca et al. Nov 2014 B2
8897891 Romero Nov 2014 B2
8923982 Howard Dec 2014 B2
8934965 Rogers et al. Jan 2015 B2
8934980 Pless et al. Jan 2015 B2
8938300 Rosero Jan 2015 B2
8938308 Meadows Jan 2015 B2
8958862 Hetke et al. Feb 2015 B2
8968331 Sochor Mar 2015 B1
8977335 Putz Mar 2015 B2
8977367 Elahi et al. Mar 2015 B2
8989864 Funderburk et al. Mar 2015 B2
9008747 Seymour et al. Apr 2015 B2
9014796 Kipke et al. Apr 2015 B2
9044590 Greenberg et al. Jun 2015 B2
9061134 Askin et al. Jun 2015 B2
9079013 Digiore et al. Jul 2015 B2
9089689 Govea Jul 2015 B2
9089690 Greenberg et al. Jul 2015 B2
9095267 Halpern et al. Aug 2015 B2
9149630 Howard et al. Oct 2015 B2
9211401 Frewin et al. Dec 2015 B2
9211402 Moffitt et al. Dec 2015 B2
9220897 Perryman et al. Dec 2015 B2
9227050 Romero Jan 2016 B2
9248272 Romero Feb 2016 B2
9248275 Digiore et al. Feb 2016 B2
9265465 Najafi et al. Feb 2016 B2
9265928 Pellinen et al. Feb 2016 B2
9283375 Moffitt et al. Mar 2016 B2
9289151 Kipke et al. Mar 2016 B2
9289596 Leven Mar 2016 B2
9295830 Pianca Mar 2016 B2
9314614 Bedenbaugh Apr 2016 B2
9358398 Moffitt et al. Jun 2016 B2
9364659 Rao Jun 2016 B1
9381347 Howard et al. Jul 2016 B2
9381348 Romero et al. Jul 2016 B2
9381356 Parker et al. Jul 2016 B2
9399128 Tooker et al. Jul 2016 B2
9403011 Mercanzini Aug 2016 B2
9427567 Romero Aug 2016 B2
9440082 Mercanzini et al. Sep 2016 B2
9474894 Mercanzini et al. Oct 2016 B2
9474895 Digiore et al. Oct 2016 B2
9498620 Romero et al. Nov 2016 B2
9517020 Shacham-Diamand et al. Dec 2016 B2
9592377 Greenberg et al. Mar 2017 B2
9604051 Vetter et al. Mar 2017 B2
9662494 Young May 2017 B2
9700715 Dou Jul 2017 B2
9743878 Drew Aug 2017 B2
9775983 Digiore et al. Oct 2017 B2
9775988 Govea et al. Oct 2017 B2
9827413 Barker et al. Nov 2017 B2
9833611 Govea et al. Dec 2017 B2
9855428 Henry et al. Jan 2018 B2
9861288 Ma et al. Jan 2018 B2
9925368 Ryu et al. Mar 2018 B2
10046165 Frewin et al. Aug 2018 B2
10441779 Mercanzini et al. Oct 2019 B2
20010051802 Woloszko et al. Dec 2001 A1
20010051819 Fischell et al. Dec 2001 A1
20020062143 Baudino et al. May 2002 A1
20020116042 Boling Aug 2002 A1
20030004553 Grill et al. Jan 2003 A1
20030023282 Barrett et al. Jan 2003 A1
20030036780 Barrett et al. Feb 2003 A1
20030060822 Schaer et al. Mar 2003 A1
20030083724 Jog et al. May 2003 A1
20030100823 Kipke et al. May 2003 A1
20030135253 Kokones et al. Jul 2003 A1
20030176892 Shalev Sep 2003 A1
20040002635 Hargrove et al. Jan 2004 A1
20040015205 Whitehurst et al. Jan 2004 A1
20040039434 Schrom et al. Feb 2004 A1
20040098074 Erickson et al. May 2004 A1
20040102828 Lowry et al. May 2004 A1
20040122335 Sackellares et al. Jun 2004 A1
20040133390 Osorio et al. Jul 2004 A1
20040138517 Osorio et al. Jul 2004 A1
20040138536 Frei et al. Jul 2004 A1
20040138720 Naisberg et al. Jul 2004 A1
20040138722 Carroll et al. Jul 2004 A1
20040152958 Frei et al. Aug 2004 A1
20040172089 Whitehurst et al. Sep 2004 A1
20040193021 Zdeblick et al. Sep 2004 A1
20040215288 Lee et al. Oct 2004 A1
20040220637 Zdeblick et al. Nov 2004 A1
20040225335 Whitehurst et al. Nov 2004 A1
20040243011 Plaza Dec 2004 A1
20040249417 Ransbury et al. Dec 2004 A1
20040254483 Zdeblick et al. Dec 2004 A1
20050004627 Gibson et al. Jan 2005 A1
20050008660 Kipke et al. Jan 2005 A1
20050010261 Luders et al. Jan 2005 A1
20050021103 DiLorenzo Jan 2005 A1
20050027284 Lozano et al. Feb 2005 A1
20050033136 Govari et al. Feb 2005 A1
20050038489 Grill Feb 2005 A1
20050049655 Boveja et al. Mar 2005 A1
20050070971 Fowler et al. Mar 2005 A1
20050070972 Wahlstrand et al. Mar 2005 A1
20050075681 Rezai et al. Apr 2005 A1
20050113882 Cameron et al. May 2005 A1
20050137647 Wallace et al. Jun 2005 A1
20050143790 Kipke et al. Jun 2005 A1
20050154419 Whitehurst et al. Jul 2005 A1
20050154425 Boveja et al. Jul 2005 A1
20050171522 Christopherson Aug 2005 A1
20050171558 Abovitz et al. Aug 2005 A1
20050182455 Thrope et al. Aug 2005 A1
20050209511 Heruth et al. Sep 2005 A1
20050209513 Heruth et al. Sep 2005 A1
20050209643 Heruth et al. Sep 2005 A1
20050222642 Przybyszewski et al. Oct 2005 A1
20050240242 DiLorenzo Oct 2005 A1
20050245988 Miesel Nov 2005 A1
20060004422 De Ridder Jan 2006 A1
20060015153 Gliner et al. Jan 2006 A1
20060030897 Gilmer et al. Feb 2006 A1
20060041295 Osypka Feb 2006 A1
20060049957 Surgenor et al. Mar 2006 A1
20060058588 Zdeblick Mar 2006 A1
20060058727 Bernabei Mar 2006 A1
20060058855 Gill Mar 2006 A1
20060084965 Young Apr 2006 A1
20060095029 Young et al. May 2006 A1
20060095105 Jog et al. May 2006 A1
20060116581 Zdeblick et al. Jun 2006 A1
20060129203 Garabedian et al. Jun 2006 A1
20060135877 Giftakis Jun 2006 A1
20060149336 Meadows Jul 2006 A1
20060149337 John Jul 2006 A1
20060149340 Karunasiri Jul 2006 A1
20060167497 Armstrong et al. Jul 2006 A1
20060173263 He et al. Aug 2006 A1
20060173510 Besio et al. Aug 2006 A1
20060178709 Foster et al. Aug 2006 A1
20060184060 Belalcazar et al. Aug 2006 A1
20060195154 Jaax et al. Aug 2006 A1
20060200206 Firlik et al. Sep 2006 A1
20060212090 Lozano et al. Sep 2006 A1
20060241717 Whitehurst et al. Oct 2006 A1
20060258951 Bleich et al. Nov 2006 A1
20060264777 Drew Nov 2006 A1
20060265022 John et al. Nov 2006 A1
20060276866 McCreery Dec 2006 A1
20060282014 Kipke et al. Dec 2006 A1
20060293720 DiLorenzo Dec 2006 A1
20060293721 Tarver et al. Dec 2006 A1
20070027498 Maschino et al. Feb 2007 A1
20070027500 Maschino et al. Feb 2007 A1
20070027514 Gerber Feb 2007 A1
20070043268 Russell Feb 2007 A1
20070060974 Lozano Mar 2007 A1
20070067002 Lozano Mar 2007 A1
20070067003 Sanchez et al. Mar 2007 A1
20070088403 Wyler et al. Apr 2007 A1
20070088404 Wyler et al. Apr 2007 A1
20070093870 Maschino Apr 2007 A1
20070100389 Jaax et al. May 2007 A1
20070100392 Maschino et al. May 2007 A1
20070100393 Whitehurst et al. May 2007 A1
20070100398 Sloan May 2007 A1
20070106143 Flaherty May 2007 A1
20070123765 Hetke et al. May 2007 A1
20070123944 Zdeblick May 2007 A1
20070135721 Zdeblick Jun 2007 A1
20070142872 Mickle et al. Jun 2007 A1
20070150024 Leyde et al. Jun 2007 A1
20070173890 Armstrong Jul 2007 A1
20070173896 Zdeblick Jul 2007 A1
20070173897 Zdeblick Jul 2007 A1
20070173901 Reeve Jul 2007 A1
20070173908 Begnaud Jul 2007 A1
20070179558 Gliner et al. Aug 2007 A1
20070179569 Zdeblick Aug 2007 A1
20070185537 Zdeblick Aug 2007 A1
20070185544 Dawant et al. Aug 2007 A1
20070185548 Zdeblick Aug 2007 A1
20070185549 Zdeblick Aug 2007 A1
20070197892 Shen et al. Aug 2007 A1
20070203537 Goetz et al. Aug 2007 A1
20070203546 Stone et al. Aug 2007 A1
20070208394 King et al. Sep 2007 A1
20070213784 Pless Sep 2007 A1
20070213785 Osorio et al. Sep 2007 A1
20070213786 Sackellares et al. Sep 2007 A1
20070219591 Zdeblick et al. Sep 2007 A1
20070225674 Molnar et al. Sep 2007 A1
20070225773 Shen et al. Sep 2007 A1
20070225774 Eskandar et al. Sep 2007 A1
20070233192 Craig Oct 2007 A1
20070249953 Frei et al. Oct 2007 A1
20070249954 Virag et al. Oct 2007 A1
20070250133 Carlson et al. Oct 2007 A1
20070255323 Werder et al. Nov 2007 A1
20070255338 Wahlstrand Nov 2007 A1
20070255374 Kolafa et al. Nov 2007 A1
20070255531 Drew Nov 2007 A1
20070265683 Ehrlich Nov 2007 A1
20070282389 Moxon et al. Dec 2007 A1
20070293908 Cowan et al. Dec 2007 A1
20080021514 Pless Jan 2008 A1
20080021517 Dietrich Jan 2008 A1
20080027289 Zdeblick Jan 2008 A1
20080027487 Patel et al. Jan 2008 A1
20080027503 Marrosu et al. Jan 2008 A1
20080027504 Bedenbaugh Jan 2008 A1
20080027514 DeMulling et al. Jan 2008 A1
20080027540 Cumming Jan 2008 A1
20080039895 Fowler et al. Feb 2008 A1
20080046012 Covalin et al. Feb 2008 A1
20080046013 Lozano Feb 2008 A1
20080058630 Robertson Mar 2008 A1
20080077186 Thompson et al. Mar 2008 A1
20080077191 Morrell Mar 2008 A1
20080103547 Okun et al. May 2008 A1
20080103548 Fowler et al. May 2008 A1
20080103578 Gerber May 2008 A1
20080114417 Leyde May 2008 A1
20080119900 DiLorenzo May 2008 A1
20080139870 Gliner et al. Jun 2008 A1
20080140152 Imran et al. Jun 2008 A1
20080154328 Thompson et al. Jun 2008 A1
20080154331 John et al. Jun 2008 A1
20080154340 Goetz et al. Jun 2008 A1
20080161881 Firlik et al. Jul 2008 A1
20080161896 Sauter-Starace et al. Jul 2008 A1
20080172103 Kao et al. Jul 2008 A1
20080177196 Burdick et al. Jul 2008 A1
20080188905 Swartz Aug 2008 A1
20080195166 Sun et al. Aug 2008 A1
20080195227 Boling et al. Aug 2008 A1
20080208283 Vetter et al. Aug 2008 A1
20080208287 Palermo et al. Aug 2008 A1
20080210592 Anderson et al. Sep 2008 A1
20080215125 Farah et al. Sep 2008 A1
20080221642 Humayun et al. Sep 2008 A1
20080242976 Robertson et al. Oct 2008 A1
20080255439 Tang et al. Oct 2008 A1
20080255629 Jenson et al. Oct 2008 A1
20080255647 Jensen et al. Oct 2008 A1
20080269835 Carlson et al. Oct 2008 A1
20080269842 Giftakis et al. Oct 2008 A1
20080269854 Hegland et al. Oct 2008 A1
20080275526 Lozano Nov 2008 A1
20080284599 Zdeblick et al. Nov 2008 A1
20080294218 Savage et al. Nov 2008 A1
20080300652 Lim et al. Dec 2008 A1
20080306394 Zdeblick et al. Dec 2008 A1
20080312726 Frank et al. Dec 2008 A1
20080316020 Robertson et al. Dec 2008 A1
20090027504 Lim et al. Jan 2009 A1
20090062879 Li et al. Mar 2009 A1
20090082645 Hafezi et al. Mar 2009 A1
20090105784 Massoud-Ansari et al. Apr 2009 A1
20090118806 Vetter et al. May 2009 A1
20090132042 Hetke et al. May 2009 A1
20090171416 Firlik et al. Jul 2009 A1
20090177144 Masmanidis et al. Jul 2009 A1
20090187196 Vetter Jul 2009 A1
20090204183 Kreidler et al. Aug 2009 A1
20090240314 Kong et al. Sep 2009 A1
20090248122 Pianca Oct 2009 A1
20090253977 Kipke et al. Oct 2009 A1
20090256702 Robertson et al. Oct 2009 A1
20090292325 Cederna et al. Nov 2009 A1
20090299174 Wright et al. Dec 2009 A1
20090306728 Wright et al. Dec 2009 A1
20090306729 Doerr Dec 2009 A1
20090312770 Kozai et al. Dec 2009 A1
20090318824 Nishida et al. Dec 2009 A1
20090325424 Aarts et al. Dec 2009 A1
20100014541 Harriman Jan 2010 A1
20100015274 Fill Jan 2010 A1
20100030298 Martens et al. Feb 2010 A1
20100036468 Decre et al. Feb 2010 A1
20100047376 Imbeau et al. Feb 2010 A1
20100069717 Hafezi et al. Mar 2010 A1
20100076536 Merz et al. Mar 2010 A1
20100087853 Kipke et al. Apr 2010 A1
20100100152 Martens et al. Apr 2010 A1
20100106178 Obermiller et al. Apr 2010 A1
20100114193 Lozano et al. May 2010 A1
20100114234 Zdeblick May 2010 A1
20100114250 Zdeblick May 2010 A1
20100130844 Williams et al. May 2010 A1
20100145216 He et al. Jun 2010 A1
20100145414 Decre et al. Jun 2010 A1
20100152747 Padiy et al. Jun 2010 A1
20100198315 Martens et al. Aug 2010 A1
20100249883 Zdeblick Sep 2010 A1
20100274305 Gliner et al. Oct 2010 A1
20100292602 Worrell et al. Nov 2010 A1
20100298908 Vardiman Nov 2010 A1
20100298917 Vardiman Nov 2010 A1
20100298918 Vardiman Nov 2010 A1
20100312188 Robertson et al. Dec 2010 A1
20100312228 Zdeblick et al. Dec 2010 A1
20100318163 Zdeblick Dec 2010 A1
20100331807 Whitehurst et al. Dec 2010 A1
20110001488 Behzadi et al. Jan 2011 A1
20110022124 Zdeblick et al. Jan 2011 A1
20110034964 Bi et al. Feb 2011 A1
20110034970 Barker Feb 2011 A1
20110040203 Savage et al. Feb 2011 A1
20110071766 Dolan et al. Mar 2011 A1
20110130809 Zdeblick Jun 2011 A1
20110152988 Whitehurst et al. Jun 2011 A1
20110154655 Hetke et al. Jun 2011 A1
20110184495 Wang et al. Jul 2011 A1
20110190860 Harberts et al. Aug 2011 A1
20110196454 Strand et al. Aug 2011 A1
20110208225 Martens et al. Aug 2011 A1
20110213382 Decre et al. Sep 2011 A1
20110218417 Boogaard et al. Sep 2011 A1
20110224757 Zdeblick et al. Sep 2011 A1
20110224765 Harberts et al. Sep 2011 A1
20110224766 Tol et al. Sep 2011 A1
20110282179 Zdeblick Nov 2011 A1
20110301665 Mercanzini et al. Dec 2011 A1
20120004520 Whitworth et al. Jan 2012 A1
20120004527 Thompson et al. Jan 2012 A1
20120004716 Langhammer et al. Jan 2012 A1
20120007734 Berkman et al. Jan 2012 A1
20120022341 Zdeblick Jan 2012 A1
20120035684 Thompson et al. Feb 2012 A1
20120053344 Lagos Gonzalez Mar 2012 A1
20120059444 Pardoel et al. Mar 2012 A1
20120062379 Hafezi et al. Mar 2012 A1
20120095355 Zdeblick Apr 2012 A1
20120109262 Martens May 2012 A1
20120109599 Martens May 2012 A1
20120116188 Frank et al. May 2012 A1
20120136420 Pardoel et al. May 2012 A1
20120150256 Martens Jun 2012 A1
20120184837 Martens et al. Jul 2012 A1
20120253442 Gliner et al. Oct 2012 A1
20120277821 Martens et al. Nov 2012 A1
20120296444 Greenberg et al. Nov 2012 A1
20120302912 Moffitt et al. Nov 2012 A1
20120303088 Van Kaam et al. Nov 2012 A1
20120303089 Martens et al. Nov 2012 A1
20120303107 Decre et al. Nov 2012 A1
20120316630 Firlik et al. Dec 2012 A1
20130009691 Blanken et al. Jan 2013 A1
20130030366 Robertson et al. Jan 2013 A1
20130046356 Jensen et al. Feb 2013 A1
20130060102 Zdeblick Mar 2013 A1
20130085361 Mercanzini et al. Apr 2013 A1
20130131754 Sarvazyan May 2013 A1
20130144132 Hafezi et al. Jun 2013 A1
20130172716 Lozano et al. Jul 2013 A1
20130193950 Hafezi et al. Aug 2013 A1
20130204318 Young Aug 2013 A1
20130223028 Arne et al. Aug 2013 A1
20130231188 Berberich et al. Sep 2013 A1
20130282090 Decre et al. Oct 2013 A1
20130345780 Tabada et al. Dec 2013 A1
20130345789 Havel et al. Dec 2013 A1
20140039578 Whitehurst et al. Feb 2014 A1
20140066999 Carcieri et al. Mar 2014 A1
20140200633 Moffitt Jul 2014 A1
20140277284 Chen et al. Sep 2014 A1
20150051678 Reed et al. Feb 2015 A1
20150105774 Lindquist et al. Apr 2015 A1
20150142090 Duijsens et al. May 2015 A1
20150151111 Pianca et al. Jun 2015 A1
20150209578 Kast et al. Jul 2015 A1
20150246233 Kaemmerer Sep 2015 A1
20150290452 Kokones et al. Oct 2015 A1
20150335258 Masmanidis Nov 2015 A1
20150355413 Bhagavatula et al. Dec 2015 A1
20150360023 Howard et al. Dec 2015 A1
20160008592 Romero et al. Jan 2016 A1
20160023003 Perryman et al. Jan 2016 A1
20160074651 Moffitt et al. Mar 2016 A1
20160144186 Kaemmerer et al. May 2016 A1
20160228706 Hershey et al. Aug 2016 A1
20160331953 Reed et al. Nov 2016 A1
20160331975 Henry et al. Nov 2016 A1
20160361535 Perryman et al. Dec 2016 A1
20170007813 Negi et al. Jan 2017 A1
20170049345 Single Feb 2017 A1
20170136238 Hartig et al. May 2017 A1
20170143982 Mercanzini May 2017 A1
20170189700 Moffitt et al. Jul 2017 A1
20170197086 Howard et al. Jul 2017 A1
20170266432 Seeley et al. Sep 2017 A1
20170296808 Greenberg et al. Oct 2017 A1
20170361101 Single Dec 2017 A1
20180154156 Clark et al. Jun 2018 A1
20180185656 Shepard et al. Jul 2018 A1
Foreign Referenced Citations (104)
Number Date Country
1261801 Aug 2000 CN
101027085 Aug 2007 CN
101600470 Dec 2009 CN
201871104 Jun 2011 CN
102274074 Dec 2011 CN
102341036 Feb 2012 CN
103619405 Mar 2014 CN
0 586 664 Mar 1994 EP
0 677 743 Oct 1995 EP
0 743 839 Nov 1996 EP
0 892 654 Jan 1999 EP
0 895 483 Feb 1999 EP
0 959 942 Dec 1999 EP
1 048 319 Nov 2000 EP
1 062 973 Dec 2000 EP
1 102 607 May 2001 EP
1 257 320 Nov 2002 EP
1 446 189 Aug 2004 EP
1 514 576 Mar 2005 EP
1 750 798 Feb 2007 EP
1 890 764 Feb 2008 EP
1 931 419 Jun 2008 EP
1 985 579 Oct 2008 EP
1 993 665 Nov 2008 EP
2 046 441 Apr 2009 EP
2 066 396 Jun 2009 EP
2 069 003 Jun 2009 EP
2 131 916 Dec 2009 EP
2 144 665 Jan 2010 EP
2 167 188 Mar 2010 EP
2 320 221 May 2011 EP
2 341 979 Jul 2011 EP
2 389 975 Nov 2011 EP
2 456 513 May 2012 EP
2 476 453 Jul 2012 EP
2 542 303 Jan 2013 EP
2 559 454 Feb 2013 EP
2 604 313 Jun 2013 EP
2 618 889 Jul 2013 EP
2 620 179 Jul 2013 EP
2 623 154 Aug 2013 EP
2 626 108 Aug 2013 EP
2 626 109 Aug 2013 EP
2 626 110 Aug 2013 EP
2 626 111 Aug 2013 EP
2 656 875 Oct 2013 EP
2 656 876 Oct 2013 EP
2 664 354 Nov 2013 EP
2 674 193 Dec 2013 EP
2 862 595 Apr 2015 EP
3 111 835 Jan 2017 EP
1 619 0439.6 Jul 2017 EP
3 231 476 Oct 2017 EP
2005-052647 Mar 2005 JP
2012-179333 Sep 2012 JP
WO-9810010 Mar 1998 WO
WO-02068042 Sep 2002 WO
WO-03022354 Mar 2003 WO
WO-03028521 Apr 2003 WO
WO-03066152 Aug 2003 WO
WO-03066153 Aug 2003 WO
WO-03066157 Aug 2003 WO
WO-2004043536 May 2004 WO
WO-2018068013 May 2004 WO
WO-2004045707 Jun 2004 WO
WO-2005002467 Jan 2005 WO
WO-2005067792 Jul 2005 WO
WO-2005112216 Nov 2005 WO
WO-2006029257 Mar 2006 WO
WO-2006047264 May 2006 WO
WO-2006047265 May 2006 WO
WO-2006104432 Oct 2006 WO
WO-2007002144 Jan 2007 WO
WO-2007009070 Jan 2007 WO
WO-2007011611 Jan 2007 WO
WO-2007025356 Mar 2007 WO
WO-2007028003 Mar 2007 WO
WO-2007042999 Apr 2007 WO
WO-2007092330 Aug 2007 WO
WO-20071 08718 Sep 2007 WO
WO-2007100428 Sep 2007 WO
WO-2008003318 Jan 2008 WO
WO-2008005478 Jan 2008 WO
WO-2008016881 Feb 2008 WO
WO-2008035285 Mar 2008 WO
WO-2008035344 Mar 2008 WO
WO-2008051463 May 2008 WO
WO-2008064269 May 2008 WO
WO-2008068759 Jun 2008 WO
WO-2008075294 Jun 2008 WO
WO-2008077440 Jul 2008 WO
WO-2008088897 Jul 2008 WO
WO-2008089726 Jul 2008 WO
WO-2008107822 Sep 2008 WO
WO-2008109298 Sep 2008 WO
WO-20081 33616 Nov 2008 WO
WO-2008133683 Nov 2008 WO
WO-2008138305 Nov 2008 WO
WO-2010014686 Feb 2010 WO
WO-2010055421 May 2010 WO
WO-2011000791 Jan 2011 WO
WO-2011115999 Sep 2011 WO
WO-2013014206 Jan 2013 WO
WO-2016030823 Mar 2016 WO
Non-Patent Literature Citations (161)
Entry
US 8,388,533 B2, 03/2013, Hafezi et al. (withdrawn)
US 8,469,885 B2, 06/2013, Hafezi et al. (withdrawn)
Foreign Action other than Search Report on EP 15760291.3 dated Apr. 23, 2021.
Non-Final Office Action on U.S. Appl. No. 15/962,632 dated May 12, 2021.
Non-Final Office Action on U.S. Appl. No. 16/551,390 dated Apr. 29, 2021.
Notice of Allowance on U.S. Appl. No. 16/531,701 dated May 25, 2021.
International Preliminary Report on Patentability on PCT/IB2019/053275 dated Nov. 5, 2020 (8 pages).
AU Examination Report on AU 2011234422 dated Feb. 11, 2014 (3 pages).
Benabid et al., “Combined (Thalamotomy and Stimulation) Stereotactic Surgery of the VIM Thalamic Nucleus for Bilateral Parkinson Disease”, Proceedings of the Meeting of the American Society for Stereotactic and Functional Neurosurgery, vol. 50, Montreal 1987 Appl. Neurophysiol., pp. 344-346 (3 pages).
Bucher et al., “Low-impedance thin-film polycrystalline silicon microelectrodes for extracellular stimulation and recording”, Biosensors & Bioelectronics, vol. 14, 1999, pp. 639-649 (11 pages).
Cogan et al., “Plasma-enhanced chemical vapor deposited silicon carbide as an implantable dielectric coating”, Journal of Biomedical Materials Research Part A 67.3, 2003, pp. 856-867 (12 pages).
Communication from the European Patent Office on EP 09795810.2 dated Sep. 14, 2011 (2 pages).
Corrected Notice of Allowability on U.S. Appl. No. 14/470,356 dated May 18, 2016 (6 pages).
Decision of Rejection and Decision for Dismissal of Amendment on JP 2011-543841 dated May 15, 2014 (6 pages).
Decision of Rejection for JP 2012-541491 dated Oct. 26, 2015 (7 pages).
EIC Biomedical, “Thin-film Encapsulation for Neural Recording and Stimulation Electrodes”, Silicon carbide and oxycarbide, Apr. 2008, pp. 1-2 (2 pages).
EPO Communication and Search Report EP 09795810.2 dated Sep. 25, 2013 (5 pages).
EPO Communication dated May 22, 2013 with Extended Search Report on EP 12198290.4-1652 dated May 13, 2013 (6 pages).
European Search Report on EP 09803534.8 dated Jul. 21, 2011 (5 pages).
European Search Report on EP 13169272.5 dated Aug. 30, 2013 (5 pages).
European Search Report on EP 16190439 dated Jul. 19, 2017 (2 pages).
Examination Report for EP 09795810.2 dated May 8, 2014 (4 pages).
Examination Report on AU 2009276603 dated Mar. 3, 2014 (3 pages).
Examination Report on EP 09795810.2 dated Jun. 22, 2012 (5 pages).
Examination Report on EP 11711884.4 dated Mar. 28, 2014 (4 pages).
Extended European Search Report for EP 19174013.3 dated Oct. 8, 2019 (7 pages).
Extended European Search Report on EP 14172592 dated Aug. 28, 2014 (8 pages).
Extended European Search Report on EP 16190439.6 dated Jul. 27, 2017 (7 pages).
Extended European Search Report on EP 16199868.7 dated Apr. 28, 2017 (7 pages).
Extended European Search Report on EP 18208814.6 dated Mar. 28, 2019 (6 pages).
Extended European Search Report on EP 19165102.5 dated Jul. 8, 2019 (7 pages).
Fierce Medical Devices, “Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker”, Feb. 20, 2014, pp. 1-3 (3 pages).
Final Office Action on U.S. Appl. No. 13/056,261 dated Jan. 9, 2014 (9 pages).
Final Office Action on U.S. Appl. No. 13/128,821 dated Dec. 14, 2012 (17 pages).
Final Office Action on U.S. Appl. No. 13/638,435 dated Jun. 30, 2015 (12 pages).
Final Office Action on U.S. Appl. No. 14/309,491 dated Mar. 3, 2016 (12 pages).
Final Office Action on U.S. Appl. No. 14/731,296 dated Apr. 6, 2017 (8 pages).
Final Office Action on U.S. Appl. No. 15/281,468 dated Jun. 14, 2017 (6 pages).
Final Office Action on U.S. Appl. No. 15/369,766 dated Feb. 23, 2018 (13 pages).
Final Office Action on U.S. Appl. No. 15/369,766 dated Feb. 7, 2019 (9 pages).
Final Office Action on U.S. Appl. No. 16/015,625 dated Dec. 28, 2018 (13 pages).
Final Office Action on U.S. Appl. No. 15/311,082 dated May 26, 2020 (14 pages).
First Office Action for CN 201580019701.2 dated Nov. 15, 2019 (18 pages).
Gibney, Michael, “St. Jude places its Nanostim leadless pacemaker in a U.K. patient”, Fierce Medical Devices, Jan. 27, 2014, pp. 1-3 (3 pages).
Hosp et al., “Thin-film epidural microelectrode arrays for somatosensory and motor cortex mapping in rat”, Journal of Neuroscience Methods, vol. 172, 2008, pp. 255-262 (8 pages).
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority on PCT/IB2017/050551 dated Aug. 16, 2018 (8 pages).
International Preliminary Report on Patentability for PCT/EP2010/068658 dated Jun. 5, 2012 (11 pages).
International Preliminary Report on Patentability on PCT/IB2009/007715 dated May 17, 2011 (9 pages).
International Preliminary Report on Patentability on PCT/IB2015/053610 dated Dec. 1, 2016 (8 pages).
International Preliminary Report on Patentability on PCT/IB2015/056437 dated Mar. 9, 2017 (7 pages).
International Preliminary Report on Patentability on PCT/IB2015/056438 dated Mar. 9, 2017 (7 pages).
International Preliminary Report on Patentability on PCT/US2009/052077 dated Feb. 1, 2011 (6 pages).
International Search Report and Written Opinion of the International Searching Authority on PCT/IB2019/051635 dated Jun. 3, 2019 (13 pages).
International Search Report and Written Opinion of the International Searching Authority on PCT/IB2019/053275 dated Jul. 4, 2019 (12 pages).
International Search Report and Written Opinion on PCT/EP2010/068658 dated Mar. 21, 2011 (18 pages).
International Search Report and Written Opinion on PCT/EP2011/055045 dated Jul. 18, 2011 (14 pages).
International Search Report and Written Opinion on PCT/IB2015/053610 dated Jul. 20, 2015 (12 pages).
International Search Report and Written Opinion on PCT/IB2015/056437 dated Nov. 5, 2015 (11 pages).
International Search Report and Written Opinion on PCT/IB2015/056438 dated Nov. 5, 2015 (11 pages).
International Search Report and Written Opinion on PCT/IB2017/050551 dated Mar. 29, 2017 (17 pages).
International Search Report and Written Opinion on PCT/US09/52077 dated Sep. 25, 2009 (8 pages).
International Search Report on PCT/IB2009/007715 dated Apr. 22, 2010 (6 pages).
Janders et al., “Novel Thin Film Titanium Nitride Micro-Electrodes With Excellent Charge Transfer Capability for Cell Stimulation and Sensing Applications”, 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1996, Amsterdam (3 pages).
Moxon et al., “Nanostructured Surface Modification of Ceramic-Based Microelectrodes to Enhance Biocompatibility for a Direct Brain-Machine Interface”, IEEE Transactions on Biomedical Engineering, vol. 51, No. 6, Jun. 2004, pp. 881-889 (9 pages).
Non-Final Office Action for U.S. Appl. No. 15/311,082 dated Jan. 10, 2020 (14 pages).
Non-Final Office Action for U.S. Appl. No. 15/910,278 dated Nov. 26, 2019 (7 pages).
Non-Final Office Action on U.S. Appl. No. 13/056,261 dated Aug. 7, 2013 (8 pages).
Non-Final Office Action on U.S. Appl. No. 13/128,821 dated Nov. 14, 2013 (8 pages).
Non-Final Office Action on U.S. Appl. No. 13/128,821 dated Apr. 24, 2012 (10 pages).
Non-Final Office Action on U.S. Appl. No. 13/512,936 dated Aug. 14, 2013 (11 pages).
Non-Final Office Action on U.S. Appl. No. 13/638,435 dated Feb. 10, 2016 (12 pages).
Non-Final Office Action on U.S. Appl. No. 13/638,435 dated Mar. 12, 2015 (15 pages).
Non-Final Office Action on U.S. Appl. No. 14/287,917 dated Sep. 26, 2014 (21 pages).
Non-Final Office Action on U.S. Appl. No. 14/309,491 dated Jul. 28, 2015 (13 pages).
Non-Final Office Action on U.S. Appl. No. 14/316,154 dated Dec. 18, 2014 (8 pages).
Non-Final Office Action on U.S. Appl. No. 14/470,423 dated Jan. 21, 2016 (12 pages).
Non-Final Office Action on U.S. Appl. No. 14/731,296 dated Nov. 22, 2017 (9 pages).
Non-Final Office Action on U.S. Appl. No. 14/731,296 dated Oct. 5, 2016 (9 pages).
Non-Final Office Action on U.S. Appl. No. 14/945,952 dated Jul. 26, 2016 (8 pages).
Non-Final Office Action on U.S. Appl. No. 15/185,709 dated Jul. 3, 2018 (17 pages).
Non-Final Office Action on U.S. Appl. No. 15/194,033 dated Aug. 22, 2016 (5 pages).
Non-Final Office Action on U.S. Appl. No. 15/281,468 dated Dec. 7, 2016 (8 pages).
Non-Final Office Action on U.S. Appl. No. 15/369,766 dated Apr. 20, 2017 (12 pages).
Non-Final Office Action on U.S. Appl. No. 15/369,766 dated Jun. 29, 2018 (9 pages).
Non-Final Office Action on U.S. Appl. No. 15/369,766 dated May 31, 2019 (10 pages).
Non-Final Office Action on U.S. Appl. No. 15/426,816 dated Mar. 21, 2017 (8 pages).
Non-Final Office Action on U.S. Appl. No. 15/878,066 dated Mar. 19, 2018 (8 pages).
Non-Final Office Action on U.S. Appl. No. 16/015,625 dated Aug. 9, 2018 (14 pages).
Non-Final Office Action on U.S. Appl. No. 15/962,632 dated Mar. 30, 2020 (10 pages).
Non-Final Office Action on U.S. Appl. No. 16/236,716 dated Apr. 29, 2020 (9 pages).
Notice of Allowance for U.S. Appl. No. 15/369,766 dated Oct. 17, 2019 (12 pages).
Notice of Allowance on U.S. Appl. No. 13/056,261 dated May 8, 2014 (8 pages).
Notice of Allowance on U.S. Appl. No. 13/128,821 dated Dec. 24, 2013 (6 pages).
Notice of Allowance on U.S. Appl. No. 13/128,821 dated Mar. 25, 2014 (7 pages).
Notice of Allowance on U.S. Appl. No. 13/512,936 dated Feb. 20, 2014 (7 pages).
Notice of Allowance on U.S. Appl. No. 13/512,936 dated Nov. 25, 2013 (7 pages).
Notice of Allowance on U.S. Appl. No. 13/638,435 dated Sep. 16, 2016 (13 pages).
Notice of Allowance on U.S. Appl. No. 14/287,917 dated Apr. 15, 2015 (5 pages).
Notice of Allowance on U.S. Appl. No. 14/287,917 dated Jul. 20, 2015 (5 pages).
Notice of Allowance on U.S. Appl. No. 14/309,491 dated May 11, 2016 (10 pages).
Notice of Allowance on U.S. Appl. No. 14/316,154 dated Apr. 20, 2015 (12 pages).
Notice of Allowance on U.S. Appl. No. 14/470,356 dated Apr. 13, 2016 (9 pages).
Notice of Allowance on U.S. Appl. No. 14/470,356 dated Mar. 18, 2016 (8 pages).
Notice of Allowance on U.S. Appl. No. 14/470,423 dated Jun. 15, 2016 (5 pages).
Notice of Allowance on U.S. Appl. No. 14/731,296 dated Aug. 15, 2018 (7 pages).
Notice of Allowance on U.S. Appl. No. 14/731,296 dated May 7, 2018 (5 pages).
Notice of Allowance on U.S. Appl. No. 14/945,952 dated Dec. 7, 2016 (5 pages).
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Jun. 10, 2019 (2 pages).
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Apr. 26, 2019 (5 pages).
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Nov. 9, 2018 (7 pages).
Notice of Allowance on U.S. Appl. No. 15/194,033 dated Oct. 27, 2016 (7 pages).
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Jun. 1, 2018 (2 pages).
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Feb. 13, 2018 (5 pages).
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Nov. 15, 2017 (8 pages).
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Jul. 27, 2018 (2 pages).
Notice of Allowance on U.S. Appl. No. 15/422,393 dated Jul. 11, 2017 (7 pages).
Notice of Allowance on U.S. Appl. No. 15/422,393 dated Aug. 14, 2017 (5 pages).
Notice of Allowance on U.S. Appl. No. 15/422,393 dated Oct. 25, 2017 (5 pages).
Notice of Allowance on U.S. Appl. No. 15/426,816 dated Oct. 12, 2017 (7 pages).
Notice of Allowance on U.S. Appl. No. 15/878,066 dated Oct. 3, 2018 (7 pages).
Notice of Allowance on U.S. Appl. No. 15/878,066 dated Dec. 5, 2018 (2 pages).
Notice of Allowance on U.S. Appl. No. 16/015,625 dated Mar. 28, 2019 (8 pages).
Notice of Allowance on U.S. Appl. No. 16/015,625 dated May 8, 2019 (8 pages).
Notice of Allowance on U.S. Appl. No. 15/369,766 dated Mar. 5, 2020 (8 pages).
Notice of Allowance on U.S. Appl. No. 15/910,278 dated Mar. 9, 2020 (8 pages).
Notice of Reasons for Rejection on JP 2011-521276 dated Mar. 3, 2014 (6 pages).
Notice of Reasons for Rejection on JP 2011-521276 dated May 30, 2013 (4 pages).
Notice of Reasons for Rejection on JP 2011 -543841 dated Oct. 21, 2013 (6 pages).
Notice of Reasons for Rejection on JP 2011-543841 dated May 30, 2013 (4 pages).
Notice of Reasons for Rejection on JP 2017-530450 dated Jul. 11, 2019 (4 pages).
Notice of Reasons for Rejections on JP 2012-541491 dated Aug. 28, 2014 (15 pages).
Office Action for CA 3026948 dated Jan. 15, 2020 (4 pages).
Office Action for EP 10787404.2 dated Mar. 26, 2013 (7 pages).
Office Action on CA 2732309 dated Dec. 7, 2015 (3 pages).
Office Action on CA 2732309 dated Nov. 8, 2016 (4 pages).
Office Action on CA 2743575 dated Jun. 11, 2015 (5 pages).
Office Action on CA 2743575 dated Sep. 14, 2015 (4 pages).
Office Action on CA 2743575 dated Jan. 21, 2015 (4 pages).
Office Action on CA 2743575 dated Sep. 25, 2014 (3 pages).
Office Action on CA 2782710 dated Aug. 14, 2017 (5 pages).
Office Action on CA 2782710 dated Oct. 19, 2016 (4 pages).
Office Action on CA 2795159 dated Dec. 18, 2018 (3 pages).
Office Action on CA 2795159 dated Jan. 27, 2017 (4 pages).
Office Action on CN 201580016170.1 dated Jan. 28, 2019 (10 pages).
Office Action on EP 10787404.2 dated May 6, 2015 (6 pages).
Office Action on EP 14172592.9 dated Aug. 20, 2015 (5 pages).
Office Action on JP 2013-501857 dated Jun. 1, 2015 (8 pages).
Office Action on JP 2013-501857 dated Sep. 17, 2014 (8 pages).
Patent Examination Report No. 1 on AU 2009315316 dated Jan. 31, 2014 (3 pages).
Patent Examination Report No. 1 on AU 2010326613 dated Jan. 30, 2014 (2 pages).
Pollak et al. “Effets de la Stimulation du Noyau Sous-Thalamique Dans La Maladie De Parkinson”, Rev. Neurol Paris, vol. 149, No. 3, pp. 175-176, Masson, Paris, 1993 (2 pages).
Rousche et al., “Flexible polyimide-based intracortical electrode arrays with bioactive capability,” IEEE Transactions on Biomedical Engineering, vol. 48, No. 3, Mar. 2001, pp. 361-371 (10 pages).
Second Notice of Reasons for Rejection on JP 2012-541491 dated Apr. 8, 2015 (10 pages).
Sepulveda et al., “Finite Element Analysis of Current Pathways with Implanted Electrodes”, J. Biomed. Eng., Jan. 1983, vol. 5, pp. 41-48 (8 pages).
Written Opinion of the International Search Authority on PCT/IB2009/07715 dated May 12, 2011 (8 pages).
Written Opinion on HU 201103393-3 dated May 2, 2012 (10 pages).
Written Opinion on PCT/EP2010/068658 dated Jun. 1, 2012 (10 pages).
Ziaie et al., “A Single-Channel Implantable Microstimulator for Functional Neuromuscular Stimulation”, IEEE Transactions on Biomedical Engineering, vol. 44, No. 10, Oct. 1997, pp. 909-920 (12 pages).
Chinese Office Action on CN 201580019701.2 dated Aug. 17, 2020 (9 pages).
Final Office Action on U.S. Appl. No. 15/962,632 dated Oct. 6, 2020 (13 pages).
International Preliminary Report on Patentability on PCT/IB2019/051635 dated Sep. 17, 2020 (7 pages).
Related Publications (1)
Number Date Country
20200306524 A1 Oct 2020 US
Continuations (1)
Number Date Country
Parent 15910278 Mar 2018 US
Child 16901583 US